Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults over 18 years of age
- People who have been diagnosed with Stage IV non-small cell lung cancer (an advanced form of lung cancer) with a specific low protein marker level (PD-L1 below 50%) and no certain gene changes that would point to other targeted treatments
- People who have signed a form agreeing to take part in the study
- People whose doctor has determined them to be suitable for a standard first-line treatment combining chemotherapy and immunotherapy
Who may not be able to join:
- People who are unable to complete questionnaires due to neurological conditions affecting the brain or nervous system
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 022643 8195
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To evaluate what kind of first line treatment for metastatic lung adenocarcinoma has a better impact on quality of life of the patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.